Skip to main content

Exact Sciences to Participate in September Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • Wells Fargo Healthcare Conference, Boston

    Fireside chat on Wednesday, September 4, 2024 at 3:45 p.m. ET

  • Baird Global Healthcare Conference, New York

    Fireside chat on Wednesday, September 11, 2024 at 10:15 a.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.92
+1.03 (0.45%)
AAPL  277.18
-0.71 (-0.26%)
AMD  221.62
+0.51 (0.23%)
BAC  53.54
-0.36 (-0.67%)
GOOG  317.75
+3.30 (1.05%)
META  656.96
-9.84 (-1.48%)
MSFT  492.02
+1.00 (0.20%)
NVDA  184.97
-0.58 (-0.31%)
ORCL  221.53
+0.99 (0.45%)
TSLA  445.17
+5.59 (1.27%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.